| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q1 2020 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| KYMERA THERAPEUTICS INC | 8 | Q3 2022 | 40.4% |
| SEER INC | 8 | Q3 2022 | 25.9% |
| RAPT THERAPEUTICS INC | 8 | Q3 2022 | 5.1% |
| SUTRO BIOPHARMA INC | 8 | Q3 2022 | 3.6% |
| ATEA PHARMACEUTICALS INC | 4 | Q3 2021 | 47.7% |
| APELLIS PHARMACEUTICALS INC | 4 | Q3 2021 | 38.8% |
| RALLYBIO CORP | 4 | Q3 2022 | 18.7% |
| XILIO THERAPEUTICS INC | 4 | Q3 2022 | 14.9% |
| CLEARSIDE BIOMEDICAL INC | 4 | Q3 2021 | 1.1% |
| MOLECULAR TEMPLATES INC | 4 | Q3 2021 | 1.0% |
View AJU IB Investment Co., Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2022-11-14 |
| 13F-HR | 2022-11-07 |
| 13F-HR | 2022-08-09 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-09 |
| 13F-HR | 2021-11-10 |
| 13F-HR | 2021-08-10 |
| 13F-HR | 2021-05-12 |
| 13F-HR | 2021-05-12 |
| 4 | 2017-11-13 |
View AJU IB Investment Co., Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.